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Thromboembolic complications have emerged as a major hazard of the nephrotic syndrome. Thrombosis
in both the arterial and venous sides of circulation has been reported. We report a case of a 22-year-old
man who suffered pulmonary embolism involving the entire left lung and right ventrobasal segment.
 2009 Elsevier Ltd. All rights reserved.1. Introduction
Pulmonary embolism (PE) is a rare complication of nephrotic
syndrome (NS). We present a case of PE involving the entire left
lung and right ventrobasal segment. The patient was administrated
without thrombolytics and recovered completely.
2. Case report
A 22-year-old young man was transferred to our hospital
because of cough and hemoptysis. He had beenwell until 3 months
earlier, when facial and both lower extremities’ edema gradually
appeared. He was admitted to local hospital on 18 December 2003.
Laboratory examinations revealed 4þ proteinuria, hypo-
proteinemia (serum albumin¼ 15.3 g/L) and hyperlipidemia (tri-
glyeride¼ 2.97 mmol/L, total cholesterol¼ 19.57 mmol/L). A
diagnosis of NS was made. Two days later, the patient underwent
a renal biopsy which revealed minimal change nephropathy.
Prednisone, benazepril, simvastatin, dipyridamole and ﬂuid
restriction were administrated to the patient. After 18 days of
hospitalization, the patient’s proteinuria resolved and he was
discharged.
Forty days after discharge (Jan 16), the patient’s proteinuria
relapsed and he was readmitted to the same hospital. The same
treatments were utilized. Two weeks later (Jan 30), the patient
developed left-side chest pain exacerbating with breath. He had.
ang).fever, tachycardia and cough accompanying with blood-tinged
sputa. He also felt chest distress and breathlessness after activity.
A chest X-ray suspected pneumonia and left pleural effusion. Anti-
biotics were added. There was no improvement after 4 days’ treat-
ment and the level of serum albumin decreased to 11.1 g/L. Cellcept
(0.5 g/d) was taken. A week later, there was still no obvious
improvement and the patient had dipstick urine of 4þ protein.
Therefore, the patient was referred to our hospital on 12 February
2004.
On admission, the temperature was 36.8 C, the pulse 88 beats
per minute, the blood pressure 100/60 mmHg, the respiratory rate
19 breaths per minute and no jugular venous distension. Serum
albuminwas 16 g/L and 24 h urinary protein excretionwas 9.3 g. An
electrocardiogram (ECG) showed no abnormal ﬁndings. Chest ﬁlm
revealed inﬁltration in the lower left lung and left pleural effusion.
Initial diagnosis was made as pneumonia secondary to NS. The
following chest CT revealed multiple patchy consolidations and an
enlargement of pulmonary artery (Fig. 1). Considering NS is a risk
factor for venous thromboembolism, further tests for suspected PE
were done. Serum ﬁbrinogenwas 5.78 g/L (2–4 g/L). Thrombin time
was 41.9 s (12–18 s). D-dimer test showed a negative result of 287
(<500 ng/mL). Antithrombin III (ATIII) level was 142 mg/L (<300 mg/
L). Lung perfusion scan revealed total absence of perfusion to the
left lung and slight nonuniform perfusion to the right ventrobasal
segment (Fig. 2). Heparin infusionwas continuously given at a dose
of 200 U/Kg per day and the patient’s condition gradually
improved. Twenty days later, he was discharged. Half a year later,
another lung perfusion scan conﬁrmed no abnormalities. Followed
up for four years, the patient recovered completely and now works
in a ship manufacturer.
Fig. 1. A: Chest CT revealed multiple patchy consolidations in the left lung seem like triangle. B: The enlargement of the pulmonary arteries (arrow). C: Interrupted left pulmonary
artery and triangular consolidations (arrow).
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The cumulative incidence of thromboembolic complications in
patients with NS is nearly 50 percent. In adults with NS, arterial
thrombosis is less common than venous thrombosis,1 and such
a large PE as described in this case is scarcely reported. Mechanisms
for hypercoagulability in the NS include: (1) abnormalities in
coagulation factors1; (2) Glucocorticoids used stimulate bone
marrow to produce more platelets; and (3) diuretics cause hypo-
volemia and pachyemia.
Glucocorticoids and immunosuppressive agents which are
widely used in the treatment of NS often cause patients into
a hypoimmunity state. Symptoms such as cough, fever, leukocytosis
and pleural effusion oftenmislead physicians to infectious diseases,
for instance, pneumonia and tuberculosis.
On January 30, the patient had a moderate pretest probability
for PE using the simpliﬁed Wells rule2 due to the combination of
immobilization, tachycardia and hemoptysis. The patient was
misdiagnosed as pneumonia for nearly a month because PE was
previously recognized as a rare disease in China which caused
clinicians’ lack of cognition and vigilance.Fig. 2. Lung perfusion scan showing total absence of perfusion to the left luD-dimer is formed when cross-linked ﬁbrin is lysed by plasmin,
and elevated levels usually occur in patients with PE. But the result
of D-dimer testing was negative in this case. After referring to the
laboratory staffs, we were informed that the level of D-dimer was
tested using an assay called immunoturbidimetry in our hospital.
This method is less sensitive than enzyme-linked immunosorbent
assay’s (ELISA). We have experienced several cases of PE with
negative D-dimer testing. So, it was suggested that the method
used should be concerned when using the negative result of
D-dimer to rule out PE. Lower sensitivity means higher probability
of misdiagnosis which may means higher mortality. Meanwhile, if
the clinical assessment is moderate or high, the D-dimer result
needs to be combined with other examinations.3
Ventilation–perfusion lung scan has been the usual initial
investigation in patients with suspected PE. When more than 3
segmental perfusion defects appeared, probability of PE is more
than 90%.3 In this case, the patient’s perfusion lung scan shows total
absence of perfusion to the left lung and slight nonuniform
perfusion to the right ventrobasal segment. It’s a strong evidence to
conﬁrm the diagnosis. Pulmonary angiography is the gold standard,
but it is expensive, invasive (mortality of about 0.5%) andng and slight nonuniform perfusion to the right ventrobasal segment.
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angiography was not adopted because the result of perfusion was
obvious and this poor patient had nephrosis.
During the whole course, the vital signs were generally stable
and the ECG was normal. There were no obvious signs of hemo-
dynamic change such as shock, which is rarely met in clinic. The
reasons supposed may include: (1) it’s a subacute PE, the right
ventricle had time to adapt and became hypertrophy as pulmonary
vascular resistance slowly increases and therefore could generate
much higher pulmonary artery pressure; (2) left lung owns only
45% of pulmonary function. The lost can be compensated by the
right lung; and (3) the patient was only 22-year-old and had no
chronic pulmonary disease previously.
In general, thrombolytic therapy is indicated only for pulmonary
embolism massive enough to threaten life or to leave the patient
with inadequate pulmonary reserve. Most patients with lesions
judged older than two weeks demonstrated little evidence of
beneﬁt from thrombolytic therapy.4 Considered 3% risk of a clini-
cally signiﬁcant hemorrhage,5 thrombolytics were not used. Anti-
coagulants such as heparin and warfarin constitute the cornerstone
of treatment for PE. This case proved that heparin alone might be
effective for such a severe PE if there were no obvious signs ofhemodynamic change. The measurement of serum ATIII is also
essential. If the level of ATIII reduced because of extra urinary loss
caused by diuretics, heparin’s antithrombotic effect will be
diminished.6
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